0001144204-12-003574.txt : 20120123 0001144204-12-003574.hdr.sgml : 20120123 20120123204002 ACCESSION NUMBER: 0001144204-12-003574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120119 FILED AS OF DATE: 20120123 DATE AS OF CHANGE: 20120123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACYCLICS INC CENTRAL INDEX KEY: 0000949699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148201 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 BUSINESS PHONE: 408 774 0330 MAIL ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER JULIAN CENTRAL INDEX KEY: 0001087939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 12540579 MAIL ADDRESS: STREET 1: BAKER BROTHERS ADVISORS STREET 2: 667 MADISON AVENUE, 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER FELIX CENTRAL INDEX KEY: 0001087940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 12540580 MAIL ADDRESS: STREET 1: BAKER BROTHERS ADVISORS STREET 2: 667 MADISON AVENUE, 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Brothers Life Sciences Capital (GP), LLC CENTRAL INDEX KEY: 0001307729 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26658 FILM NUMBER: 12540581 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER NAME: FORMER CONFORMED NAME: Baker Biotech Capital III (GP), LLC DATE OF NAME CHANGE: 20041103 4 1 form447614_20120123083920-.xml X0304 4 2012-01-19 0 0000949699 PHARMACYCLICS INC PCYC 0001307729 Baker Brothers Life Sciences Capital (GP), LLC 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY US 10065 0 0 1 0 0001087940 BAKER FELIX 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY US 10065 0 0 1 0 0001087939 BAKER JULIAN 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY US 10065 0 0 1 0 Common Stock 2012-01-19 4 P 0 22081 16.0682 A 7625736 I Through Partnership Common Stock 2012-01-19 4 P 0 10327 16.0686 A 7636063 I Through Partnership Common Stock 2012-01-19 4 P 0 2449 15.8091 A 7638512 I Through Partnership Common Stock 2012-01-20 4 P 0 178921 16.4096 A 7817433 I Through Partnership Common Stock 2012-01-20 4 P 0 69245 16.4338 A 7886678 I Through Partnership Common Stock 2012-01-20 4 X 0 16200 15 A 7902878 I Through Partnership Common Stock 2012-01-20 4 X 0 8700 15 A 7911578 I Through Partnership Common Stock 2012-01-23 4 P 0 43644 16.8975 A 7955222 I Through Partnership Common Stock 2012-01-23 4 P 0 72997 16.8784 A 8028219 I Through Partnership Common Stock 2012-01-23 4 P 0 45574 16.8399 A 8073793 I Through Partnership Call Option 15 2012-01-19 4 P 0 162 1.25 A 2012-01-19 2012-01-21 Common Stock 16200 162 I Through Partnership Call Option 15 2012-01-20 4 P 0 87 1.4976 A 2012-01-20 2012-01-21 Common Stock 8700 249 I Through Partnership Call Option 15 2012-01-20 4 X 0 162 1.25 D 2012-01-19 2012-01-21 Common Stock 16200 87 I Through Partnership Call Option 15 2012-01-20 4 X 0 87 1.4976 D 2015-01-20 2012-01-21 Common Stock 8700 0 I Through Partnership In addition to Baker Brothers Life Sciences Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Brothers Life Sciences Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (Continued in footnote 2). However, the Reporting Persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein. Represents securities owned directly by Baker Brothers Life Sciences, L.P., the sole general partner of which is Baker Brothers Life Sciences Capital, L.P., a limited partnership the sole general partner of which is Baker Brothers Life Sciences Capital (GP),LLC. Julian C. Baker and Felix J. Baker are the controlling members of Baker Brothers Life Sciences Capital (GP), LLC. /s/ Julian C. Baker, as Managing Member of Baker Brothers Life Sciences Capital (GP), LLC 2012-01-23 /s/ Julian C. Baker 2012-01-23 /s/ Felix J. Baker 2012-01-23